While France is known as the second largest hemp producer in the world, it remains one of the less developed cannabis markets. Nevertheless with the launch of the pilot program on medical cannabis in March 2021 and the expected changes in the CBD regulation following the CJEU’s decision of November 19, 2020, more and more companies are exploring options and opportunities to enter the French market where substantial growth is expected to be seen in the coming years. The purpose of this webinar is to provide a clear overview of the current regulatory landscape in France on both medical cannabis and wellness hemp/CBD and to answer some frequently asked questions in order to provide some practical tips as to what can be done or not and what to expect in the near future.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.
(Default credit disclaimer updated 02.08.2024)
For current accreditation status, please select your jurisdiction below.
French law | Available after Purchase |
EU & Germany: Annual Review 2020 and Outlook 2021 by KFN+ | Available after Purchase |
cahier des charges cannabis thérapeutique (322.1 KB) | Available after Purchase |
CJEU - Judgement of November 19, 2020 (8.3 MB) | Available after Purchase |
EIHA Position paper on CBD Feb 2021 (308 KB) | Available after Purchase |
INCBA Blog article - Kanavape case (484.1 KB) | Available after Purchase |
Medical Cannabis in France - Regulatory landscape and specifications of the pilot programme (598.7 KB) | Available after Purchase |
Jason Moscovici is a lawyer, biochemist, and founder of Provisions Legal Services, a Canadian law firm specialized in regulated industries. His practice focuses on intellectual property and regulatory compliance in fields such as cannabis, pharmaceuticals, medical devices, cosmetics, personal care products, nicotine delivery and natural health products.
Jason’s focus on the valorization and enforcement of IP, as well as the numerous compliance issues that orbit regulated businesses, have allowed him to become one of the most trusted legal advisors to the emerging international cannabis industry. His perspectives on innovation, and the commercial hurdles related specifically to the area of controlled substances old and new, are routinely solicited by industry groups and other stakeholders in this space. He sits on several committees and working groups dedicated to identifying and establishing international legal practices in these areas.
Marie Sanchez is a lawyer at the Bars of Paris and Quebec. After beginning her career in Singapore with a large pharmaceutical group, she worked for nearly 10 years in renowned international law firms before founding NOOA Avocats.
A specialist in regulatory and contractual aspects related to life sciences, she has also developed expertise in the field of therapeutic cannabis and well-being hemp. She regularly intervenes in the context of training courses as well as in conferences, in France and abroad.
She holds a Master II Professional in Health Industry Law from the University of Montpellier I as well as an ESSEC-Mannheim Executive MBA.
5 |
|
4 |
|
3 |
|
2 |
|
1 |
|